Workflow
Coherent (COHR) Surpasses Q1 Earnings and Revenue Estimates
ZACKS· 2025-11-06 07:36
Coherent (COHR) came out with quarterly earnings of $1.16 per share, beating the Zacks Consensus Estimate of $1.04 per share. This compares to earnings of $0.74 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of +11.54%. A quarter ago, it was expected that this Laser and optics manufacturer would post earnings of $0.93 per share when it actually produced earnings of $1, delivering a surprise of +7.53%.Over the last four quarters, ...
Dianthus Therapeutics, Inc. (DNTH) Reports Q3 Loss, Lags Revenue Estimates
ZACKS· 2025-11-06 07:36
Dianthus Therapeutics, Inc. (DNTH) came out with a quarterly loss of $0.97 per share versus the Zacks Consensus Estimate of a loss of $0.86. This compares to a loss of $0.74 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of -12.79%. A quarter ago, it was expected that this company would post a loss of $0.86 per share when it actually produced a loss of $0.88, delivering a surprise of -2.33%.Over the last four quarters, the compa ...
Alpha and Omega Semiconductor (AOSL) Q1 Earnings Beat Estimates
ZACKS· 2025-11-06 07:36
Alpha and Omega Semiconductor (AOSL) came out with quarterly earnings of $0.13 per share, beating the Zacks Consensus Estimate of $0.1 per share. This compares to earnings of $0.21 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of +30.00%. A quarter ago, it was expected that this chipmaker would post a loss of $0.01 per share when it actually produced earnings of $0.02, delivering a surprise of +300%.Over the last four quarters, ...
Fair Isaac (FICO) Surpasses Q4 Earnings and Revenue Estimates
ZACKS· 2025-11-06 07:36
Fair Isaac (FICO) came out with quarterly earnings of $7.74 per share, beating the Zacks Consensus Estimate of $7.34 per share. This compares to earnings of $6.54 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of +5.45%. A quarter ago, it was expected that this financial services company would post earnings of $7.73 per share when it actually produced earnings of $8.57, delivering a surprise of +10.87%.Over the last four quarter ...
Jazz Pharmaceuticals (JAZZ) Q3 Earnings and Revenues Beat Estimates
ZACKS· 2025-11-06 07:36
Jazz Pharmaceuticals (JAZZ) came out with quarterly earnings of $8.13 per share, beating the Zacks Consensus Estimate of $5.74 per share. This compares to earnings of $6.61 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of +41.64%. A quarter ago, it was expected that this drugmaker would post a loss of $6.12 per share when it actually produced a loss of $8.25, delivering a surprise of -34.8%.Over the last four quarters, the comp ...
Envela Corporation (ELA) Tops Q3 Earnings and Revenue Estimates
ZACKS· 2025-11-06 07:36
Envela Corporation (ELA) came out with quarterly earnings of $0.13 per share, beating the Zacks Consensus Estimate of $0.06 per share. This compares to earnings of $0.06 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of +116.67%. A quarter ago, it was expected that this company would post earnings of $0.05 per share when it actually produced earnings of $0.11, delivering a surprise of +120%.Over the last four quarters, the compa ...
Xencor (XNCR) Reports Q3 Loss, Misses Revenue Estimates
ZACKS· 2025-11-06 07:36
Xencor (XNCR) came out with a quarterly loss of $0.08 per share versus the Zacks Consensus Estimate of a loss of $0.72. This compares to a loss of $0.71 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of +88.89%. A quarter ago, it was expected that this biotech developing antibodies for severe autoimmune/allergic diseases and cancer would post a loss of $0.78 per share when it actually produced a loss of $0.41, delivering a surpr ...
NCR Atleos (NATL) Q3 Earnings and Revenues Beat Estimates
ZACKS· 2025-11-06 07:36
NCR Atleos (NATL) came out with quarterly earnings of $1.09 per share, beating the Zacks Consensus Estimate of $1.01 per share. This compares to earnings of $0.89 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of +7.92%. A quarter ago, it was expected that this provider of ATM services would post earnings of $0.85 per share when it actually produced earnings of $0.93, delivering a surprise of +9.41%.Over the last four quarters, ...
DBS Third-Quarter Net Profit Dips 2.0%
WSJ· 2025-11-06 07:36
DBS Group, Singapore's largest bank, reported a decrease in third quarter net profit due to impact of global minimum tax. ...
SureNano Announces Private Placement
Newsfile· 2025-11-06 07:36
Vancouver, British Columbia--(Newsfile Corp. - November 5, 2025) - SURENANO SCIENCE LTD. (CSE: SURE) (OTCQB: SURNF) (the "Company" or "SureNano") announces its intention to complete a private placement for proceeds of up to $1,250,000 (the "Private Placement"). The Private Placement will consist of the sale of up to 10,000,000 units (each a "Unit") at a price of $0.125 per Unit. Each Unit will be comprised of one common share (a "Common Share") and one Common Share purchase warrant (each a "Warrant"), with ...